CURE:ARCA-Direxion Daily Healthcare Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 125.45

Change

+0.09 (+0.07)%

Market Cap

USD 0.17B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the Health Care Select Sector Index. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the Health Care Select Sector Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is provided by Standard & Poor's and includes domestic companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Inception Date: 15/06/2011

Primary Benchmark: S&P Health Care Select Sector TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.97%

Management Expense Ratio: 1.06 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 10.94B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 5.97B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 4.66B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 4.21B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

N/A

USD 4.15B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 3.23B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 2.73B
FAS Direxion Daily Financial Bull .. 1.04 %

N/A

USD 2.45B
TNA Direxion Daily Small Cap Bull .. 1.10 %

N/A

USD 2.23B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 0.96B

ETFs Containing CURE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.30% 75% C 93% A
Dividend Return 0.35% 60% D- 20% F
Total Return 23.65% 75% C 93% A
Trailing 12 Months  
Capital Gain 34.89% 48% F 84% B
Dividend Return 2.06% 73% C 31% F
Total Return 36.96% 45% F 84% B
Trailing 5 Years  
Capital Gain 125.67% 80% B- 89% A-
Dividend Return 5.27% 71% C- 18% F
Total Return 130.94% 80% B- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 20.47% 60% D- 85% B
Dividend Return 20.90% 60% D- 84% B
Total Return 0.43% 46% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 40.21% 84% B 25% F
Risk Adjusted Return 51.97% 93% A 79% B-
Market Capitalization 0.17B 1% F 1% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.